← Back
$RLAY All transactions

Relay Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$3K

Shares

981

Price

$3

Filed

Apr 30

Insider

Name

Catinazzo Thomas

Title

Chief Financial Officer

CIK

0001818261

Roles

Officer

Transaction Details

Transaction Date

2025-04-28

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

371,877

Footnotes

Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,722 shares of restricted stock units ("RSUs") on April 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs. | Includes 248,632 shares underlying RSUs. | The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2024. | Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 42,392 shares of RSUs on April 29, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs. | Includes 206,240 shares underlying RSUs.

Filing Info

Accession No.

0000950170-25-061366

Form Type

4

Issuer CIK

0001812364

Catinazzo Thomas's History

Date Ticker Type Value
2026-04-09 RLAY M $9K
2026-04-09 RLAY $27K
2026-04-09 RLAY M $0
2026-04-07 RLAY $230K
2025-10-28 RLAY $158K
2025-07-29 RLAY $68K
2025-07-28 RLAY $6K
2025-04-29 RLAY $11K
2025-04-28 RLAY $5K
2025-04-28 RLAY $3K

Other Insiders at RLAY (90d)

Insider Bought Sold Last
Catinazzo Thomas
Chief Financial Officer
$257K 2026-04-09